Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis.
The Balance Between Immune Activation and Tolerance in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorders and MOG Antibody-Associated Disease.
Cellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications.
Divergent Trends in Relapse Activity and Relapse-Independent Progression Over Two Decades in Multiple Sclerosis.
F-Wave-Induced Repetitive Discharges: Expanding the Spectrum of Stimulus-Induced Repetitive Discharges.
Corrigendum to "Prognostic effect of serum glial fibrillary acidic protein and neurofilament light chain for predicting progression independent of relapse activity in multiple sclerosis: A systematic review" [Multiple Sclerosis and Related Disorders 114 (
Erratum to "Tolebrutinib liver safety: A detailed overview" [Multiple Sclerosis and Related Disorders 113 (2026) 107404].
Parenchymal Neuro-Behçet disease with heterogeneous clinical presentations: a comparative case report.
Patient counseling across neurologic subspecialties-a single academic center study.
Pages
« first
‹ previous
…
1131
1132
1133
1134
1135
1136
1137
1138
1139